GDLSK

USTR

FURTHER EXTENSION OF CERTAIN COVID-RELATED CHINA 301 EXCLUSIONS

The USTR has announced that it is further extending certain China 301 exclusions that had been put in place and/or previously extended to help address the COVID-19 pandemic.  The 81 exclusions at issue, which had been extended through May 31, 2022, are now being further extended through November 30, 2022. The extensions are effective for […]

USTR INITIATES REVIEW PROCESS OF CONTINUATION OF CHINA 301 DUTIES

The Office of the United States Trade Representative (“USTR”) has announced the commencement of its mandatory four-year review of the China 301 duties put in place in connection with the investigation of China’s Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation.  The actions under review are those that took effect on […]

4.4.2022 CHINA 301 LITIGATION UPDATE

On April 1, 2022, the three-judge panel at the U.S. Court of International Trade (CIT) hearing the challenge to the United States Trade Representative’s (USTR) imposition of List 3 and List 4A Section 301 additional duties on certain goods from China (In Re Section 301 Cases, Court No. 21-00052) issued an initial decision on the […]

USTR REINSTATES 352 EXPIRED CHINA 301 EXCLUSIONS

On March 23, 2022, the Office of the United States Trade Representative (USTR) announced its determination to reinstate 352 expired China 301 exclusions.  The reinstated exclusions will apply to merchandise imported between October 12, 2021 and December 31, 2022. This action follows the solicitation of public comments in connection with the USTR’s evaluation of 549 […]

U.S. ANNOUNCES DEAL WITH JAPAN TO PARTIALLY ROLLBACK SECTION 232 STEEL TARIFFS

On February 7, 2022, the USTR announced a deal to partially rollback the Section 232 tariffs on steel from Japan through the use of a tariff rate quota (“TRQ”).  The TRQ will be set to allow for the importation of historically-based volumes of Japan steel products without the assessment of Section 232 tariffs.  Highlights of […]

EXTENSION OF CERTAIN COVID-RELATED CHINA 301 EXCLUSIONS

In a notice scheduled for publication in the Federal Register on November 16, 2021, the USTR has announced that it is extending certain China 301 exclusions that had been put in place and/or previously extended to help address the COVID-19 pandemic. Based on a variety of factors, including the consideration of public comments, the USTR […]

THREE COUNTRIES TO BE DROPPED FROM THE AGOA PROGRAM IN THE ABSENCE OF URGENT POLICY CHANGES

On November 2, 2021, the U.S. Trade Representative (USTR) announced that Guinea, Mali and Ethiopia will be terminated from the African Growth and Opportunity Act (AGOA) program, effective January 1, 2022, in the absence of urgent internal policy changes. The administration expressed concern over unconstitutional government changes in Guinea and Mali, and gross violations of […]

GDLSK TO SPEAK ON HOT BUTTON ISSUES IN TRADE WITH CHINA, WITH AN EMPHASIS ON CHINA 301 AND FORCED LABOR ISSUES

On October 20, 2021, GDLSK’s Arthur Bodek and Kristina Barry will be speaking on hot button issues in trade with China, with an emphasis on China 301 and forced labor issues. Trade with China continues to involve a fast-evolving landscape, with the USTR recently laying out the Biden-Harris Administration’s New Approach to the U.S. – […]

USTR REMARKS ON THE ADMINISTRATION’S NEW APPROACH TO THE U.S.-CHINA TRADE RELATIONSHIP – INCLUDES POSSIBILITY OF NEW 301 TARIFFS AND EXCLUSIONS

On October 4, 2021, USTR Katherine Tai spoke to the Center for Strategic and International Studies on the future of the U.S. trade relationship with China.  Highlights of Ambassador Tai’s comments follow: The U.S. will restart a targeted China 301 tariff exclusion process to mitigate the effects of certain Section 301 tariffs that have not […]

USTR EXTENDS EXPIRING CHINA 301 TARIFF EXCLUSIONS ON CERTAIN MEDICAL CARE PRODUCTS THROUGH NOVEMBER 14, 2021

The Office of the United States Trade Representative (“USTR”) announced that it is temporarily extending the China 301 tariff exclusions on 99 medical care products through November 14, 2021. On December 29, 2020, in response to the evolving COVID-19 situation, the USTR had announced that it was extending expiring China 301 tariff exclusions on certain […]